Xenetic Biosciences (XBIO) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Xenetic Biosciences Inc (XBIO) Prix de l'Action, Cotation, Actualités et Historique

XBIONASDAQ

Trade with Public

Trade with Public

$1.98

-0.02-1%

Dern. MÀJ: Oct 22, 8:57 AM

$2.02

0.021%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Comparer Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$1.98

Volume / Moy.

574.00 / 86.03K

Fourchette Journalière

- - -

Plage 52 Sem.

1.85 - 4.94

Capitalisation Boursière

$4.73M

Ratio P/E

-

Rendement des Dividendes

-

Échange

NASDAQ

RSI

34

Intérêt à Découvert

0.57%

Jours pour Couvrir

1

Actualités Récentes de Xenetic Biosciences Inc

Crude Oil Down Over 3%; US Business Inventories Surge In July

U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.

Avi Kapoor

Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition

Xenetic Biosciences plans to acquire Santersus in an all-stock deal, forming Santersus Bio to tackle NET-driven diseases.

Vandana Singh

Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates

U.S. stocks edged higher as strong retail sales lifted sentiment; utilities gained, energy fell, oil dropped, while European and Asian markets advanced.

Avi Kapoor

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Henry Khederian

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.

Dylan Berman

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

-2.31M

Flux de Trésorerie d'Investissement (TTM)

-

Flux de Trésorerie de Financement (TTM)

-

Flux de Trésorerie Libre (TTM)

-2.31M

Dépenses en Capital (TTM)

-

Variation Nette de la Trésorerie (TTM)

1.69M

Métriques de Valorisation

Valeur Entreprise

-$1.77M

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

1.28

Ratio P/B (TTM)

0.77

Rendement des Bénéfices % (TTM)

-57.28%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

-

Valeur Comptable / Action

$2.59

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-

Trésorerie Totale

$6.47M

Dette sur Capitaux Propres

-

Émission de Dette (TTM)

-

Remboursement de la Dette (TTM)

-